From: PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma
Dataset | Ontology | ID | Description | P.adjust | Count |
---|---|---|---|---|---|
GSE42352 | BP | GO:0030198 | Extracellular matrix organization | 4.25E−15 | 22 |
GSE42352 | BP | GO:0043062 | Extracellular structure organization | 4.25E−15 | 22 |
GSE42352 | BP | GO:0019882 | Antigen processing and presentation | 1.98E−10 | 15 |
GSE42352 | BP | GO:0002478 | Antigen processing and presentation of exogenous peptide antigen | 8.65E−10 | 13 |
GSE42352 | BP | GO:0019884 | Antigen processing and presentation of exogenous antigen | 1.25E−09 | 13 |
GSE42352 | BP | GO:0048002 | Antigen processing and presentation of peptide antigen | 1.79E−09 | 13 |
GSE42352 | BP | GO:0034341 | Response to interferon-gamma | 3.09E−09 | 13 |
GSE42352 | BP | GO:0071346 | Cellular response to interferon-gamma | 1.19E−08 | 12 |
GSE42352 | BP | GO:0002697 | Regulation of immune effector process | 0.000287702 | 12 |
GSE42352 | BP | GO:0043312 | Neutrophil degranulation | 0.00042594 | 12 |
GSE42352 | CC | GO:0062023 | Collagen-containing extracellular matrix | 1.39E−19 | 26 |
GSE42352 | CC | GO:0010008 | Endosome membrane | 9.35E−07 | 14 |
GSE42352 | CC | GO:0030139 | Endocytic vesicle | 4.96E−08 | 13 |
GSE42352 | CC | GO:0005765 | Lysosomal membrane | 2.61E−07 | 13 |
GSE42352 | CC | GO:0098852 | Lytic vacuole membrane | 2.61E−07 | 13 |
GSE42352 | CC | GO:0005774 | Vacuolar membrane | 1.09E−06 | 13 |
GSE42352 | CC | GO:0042611 | MHC protein complex | 1.00E−17 | 11 |
GSE42352 | CC | GO:0005581 | Collagen trimer | 1.39E−11 | 11 |
GSE42352 | CC | GO:0030666 | Endocytic vesicle membrane | 1.26E−08 | 11 |
GSE42352 | CC | GO:0030133 | Transport vesicle | 2.34E−05 | 11 |
GSE42352 | MF | GO:0005201 | Extracellular matrix structural constituent | 3.04E−17 | 18 |
GSE42352 | MF | GO:0033218 | Amide binding | 1.06E−08 | 15 |
GSE42352 | MF | GO:0042277 | Peptide binding | 1.06E−08 | 14 |
GSE42352 | MF | GO:0005518 | Collagen binding | 1.21E−10 | 10 |
GSE42352 | MF | GO:0004175 | Endopeptidase activity | 0.010282087 | 8 |
GSE42352 | MF | GO:0042605 | Peptide antigen binding | 1.02E−08 | 7 |
GSE42352 | MF | GO:0019838 | Growth factor binding | 8.98E−05 | 7 |
GSE42352 | MF | GO:0003823 | Antigen binding | 0.000230162 | 7 |
GSE42352 | MF | GO:0005539 | Glycosaminoglycan binding | 0.001734373 | 7 |
GSE42352 | MF | GO:1901681 | Sulfur compound binding | 0.002670804 | 7 |
Target-OS | BP | GO:0030198 | Extracellular matrix organization | 6.15E−12 | 41 |
Target-OS | BP | GO:0043062 | Extracellular structure organization | 6.15E−12 | 41 |
Target-OS | BP | GO:0031589 | Cell-substrate adhesion | 2.67E−07 | 33 |
Target-OS | BP | GO:0001655 | Urogenital system development | 0.000137365 | 27 |
Target-OS | BP | GO:0034329 | Cell junction assembly | 0.010818905 | 25 |
Target-OS | BP | GO:0072001 | Renal system development | 0.00046375 | 24 |
Target-OS | BP | GO:0001503 | Ossification | 0.014822976 | 24 |
Target-OS | BP | GO:0001822 | Kidney development | 0.00057211 | 23 |
Target-OS | BP | GO:0007178 | Transmembrane receptor protein serine/threonine kinase signaling pathway | 0.00844363 | 23 |
Target-OS | BP | GO:0030111 | Regulation of Wnt signaling pathway | 0.016578746 | 22 |
Target-OS | CC | GO:0062023 | Collagen-containing extracellular matrix | 1.28E−09 | 38 |
Target-OS | CC | GO:0005925 | Focal adhesion | 2.57E−09 | 37 |
Target-OS | CC | GO:0030055 | Cell-substrate junction | 2.83E−09 | 37 |
Target-OS | CC | GO:0031252 | Cell leading edge | 9.36E−05 | 28 |
TargetOS | CC | GO:0005743 | Mitochondrial inner membrane | 0.001986238 | 27 |
Target-OS | CC | GO:0005759 | Mitochondrial matrix | 0.043195064 | 22 |
Target-OS | CC | GO:0031253 | Cell projection membrane | 0.002293285 | 21 |
Target-OS | CC | GO:0045121 | Membrane raft | 0.003431572 | 20 |
Target-OS | CC | GO:0098857 | Membrane microdomain | 0.003431572 | 20 |
Target-OS | CC | GO:0098589 | Membrane region | 0.005357409 | 20 |
Target-OS | MF | GO:0050839 | Cell adhesion molecule binding | 1.46E−08 | 43 |
Target-OS | MF | GO:0005201 | Extracellular matrix structural constituent | 3.19E−08 | 23 |
Target-OS | MF | GO:0005178 | Integrin binding | 2.43E−05 | 17 |
Target-OS | MF | GO:0019838 | Growth factor binding | 0.00016495 | 16 |
Target-OS | MF | GO:0030020 | Extracellular matrix structural constituent conferring tensile strength | 0.00016495 | 9 |
Target-OS | MF | GO:0003779 | Actin binding | 0.000286309 | 30 |
Target-OS | MF | GO:0048407 | Platelet-derived growth factor binding | 0.000577035 | 5 |
Target-OS | MF | GO:0045296 | Cadherin binding | 0.001118768 | 24 |
Target-OS | MF | GO:0051015 | Actin filament binding | 0.002243868 | 17 |
Target-OS | MF | GO:0008237 | Metallopeptidase activity | 0.029742453 | 14 |